hCCR9
Nomenclature
C57BL/6JSmo-Ccr9tm1(hCCR9)Smoc
Cat. NO.
NM-HU-242414
Strain State
Repository Live
Gene Summary
Gene Symbol
Ccr9
Model Description
Validation Data

Fig.1 Detection of CCR9 expression in thymus by RT-PCR.
Thymus RNA was extracted from male 8-10-week-old wild-type C57BL/6 mice (WT) and heterozygous hCCR9 knockin mice (HE), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human mRNA primers. Mouse Ccr9 mRNA (188 bp) was detectable in all mice. Human CCR9 mRNA (164 bp) was detectable only in heterozygous hCCR9 knockin mice but not in wild-type mice.

Fig.2 Detection of CCR9 expression on T cells in thymus of WT C57BL/6 mice and HO hCCR9 mice by FACS. hCCR9 was exclusively detectable in hCCR9 humanized mice but not in wild-type mice. hCCR9 was exclusively detectable on T cells in hCCR9 humanized mice, whereas mCCR9 was exclusively detectable on T cells in wild-type C57BL/6 mice. Leukocytes were collected from thymus of wild-type C57BL/6 mice (female, 9 weeks old) and homozygous hCCR9 humanized mice (female, 9 weeks old), and analyzed by flow cytometry with anti-mCCR9 and anti-hCCR9.
Abbr. HO, homozygous; WT, wild type.

Fig.3 Detection of CCR9 expression on T cells in spleen of WT C57BL/6 mice and HO hCCR9 mice by FACS. hCCR9 was exclusively detectable in hCCR9 humanized mice but not in wild-type mice. hCCR9 was exclusively detectable on T cells in hCCR9 humanized mice, whereas mCCR9 was exclusively detectable on T cells in wild-type C57BL/6 mice. Leukocytes were collected from spleen of wild-type C57BL/6 mice (female, 9 weeks old) and homozygous hCCR9 humanized mice (female, 9 weeks old), and analyzed by flow cytometry with anti-mCCR9 and anti-hCCR9.
Abbr. HO, homozygous; WT, wild type.
You may also like
Workshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreShanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more